Consolidated Balance Sheet

Cyfuse Biomedical K.K. - Filing #7337491

Concept As at
2024-03-31
As at
2023-12-31
Consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
3,555,547,000 JPY
3,873,773,000 JPY
Accounts receivable - other
8,000 JPY
6,000 JPY
Accounts receivable - trade
8,168,000 JPY
17,118,000 JPY
Merchandise and finished goods
40,217,000 JPY
34,856,000 JPY
Prepaid expenses
20,602,000 JPY
16,460,000 JPY
Other
2,000 JPY
431,000 JPY
Advance payments to suppliers
JPY
897,000 JPY
Current assets
3,682,535,000 JPY
3,987,440,000 JPY
Non-current assets
221,306,000 JPY
227,368,000 JPY
Investments and other assets
52,504,000 JPY
53,024,000 JPY
Investments in capital
10,000 JPY
10,000 JPY
Non-current assets
Property, plant and equipment
163,777,000 JPY
169,970,000 JPY
Property, plant and equipment
Intangible assets
Patent right
2,485,000 JPY
2,640,000 JPY
Other
500,000 JPY
500,000 JPY
Other intangible assets
Intangible assets
5,025,000 JPY
4,374,000 JPY
Software
2,039,000 JPY
1,233,000 JPY
Investments and other assets
Assets
3,903,842,000 JPY
4,214,809,000 JPY
Liabilities and net assets
Non-current liabilities
340,500,000 JPY
345,000,000 JPY
Long-term borrowings
340,500,000 JPY
345,000,000 JPY
Current liabilities
568,051,000 JPY
666,339,000 JPY
Short-term borrowings
450,000,000 JPY
550,000,000 JPY
Accounts payable - other
47,276,000 JPY
30,994,000 JPY
Accrued expenses
17,834,000 JPY
19,904,000 JPY
Deposits received
7,814,000 JPY
8,447,000 JPY
Liabilities
908,551,000 JPY
1,011,339,000 JPY
Shareholders' equity
2,981,220,000 JPY
3,202,767,000 JPY
Share capital
1,284,810,000 JPY
1,283,445,000 JPY
Capital surplus
3,906,737,000 JPY
3,905,372,000 JPY
Retained earnings
-2,210,328,000 JPY
-1,986,050,000 JPY
Share acquisition rights
14,070,000 JPY
702,000 JPY
Net assets
2,995,290,000 JPY
3,203,469,000 JPY
Liabilities and net assets
3,903,842,000 JPY
4,214,809,000 JPY
Liabilities
Non-current liabilities
Current liabilities
Current portion of long-term borrowings
18,000,000 JPY
18,000,000 JPY
Income taxes payable
7,512,000 JPY
16,503,000 JPY
Advances received
JPY
2,210,000 JPY
Unearned revenue
19,000,000 JPY
19,000,000 JPY
Net assets
Shareholders' equity

Talk to a Data Expert

Have a question? We'll get back to you promptly.